S100A1 and myocardial infarction: Potential clinical relevance for ischemia-released S100A1 as a direct molecular link between cardiomyocyte death and beneficial post-MI healing emanates from the fact that neutralization of extracellular S100A1 enlarged MI size and enhanced pro-fibrotic marker expression.